PATENT CLAIM ANALYSIS

Application Number: 15758861
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "233800"]

Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same.

Claim (Index 1):
A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: L 1  is a covalent bond or an optionally substituted straight or branched saturated or unsaturated bivalent hydrocarbon chain wherein one or more methylene units of L 1  are optionally and independently replaced by \u2014N(R)\u2014, \u2014N(R)C(O)\u2014, \u2014C(O)N(R)\u2014, \u2014N(R)S(O) 2 \u2014, \u2014S(O) 2 N(R)\u2014, \u2014O\u2014, \u2014C(O)\u2014, \u2014OC(O)\u2014, \u2014C(O)O\u2014, \u2014S\u2014, \u2014S(O)\u2014, \u2014S(O) 2 \u2014, or -Cy-; each R is independently hydrogen, or an optionally substituted group selected from C 1-6  aliphatic, phenyl, 4-7 membered saturated or partially unsaturated heterocyclic having 1-2 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or 5-6 membered heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or:\n two R groups on the same nitrogen are taken together with their intervening atoms to form a 4-7 membered saturated, partially unsaturated, or heteroaryl ring having 0-3 heteroatoms, in addition to the nitrogen, independently selected from nitrogen, oxygen, or sulfur; \n each -Cy- is independently an optionally substituted bivalent ring selected from 3-7 membered saturated or partially unsaturated monocyclic or bicyclic carbocyclylene, monocyclic or bicyclic arylene, 4-10 membered saturated or partially unsaturated monocyclic or bicyclic heterocyclylene having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or 5-10 membered saturated or partially unsaturated monocyclic or bicyclic heteroarylene having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur; and R 1  is a monovalent derivative of an additional therapeutic agent.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 90.0
- Lexical Diversity: 1.06667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15807293', '14150230', '13939816', '13939787', '14496501']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7489076293201702
- 35 USC 102 Novelty (BERT): 0.5099950150727559
- Combined Prediction Score: 0.7250163678954288
- Mean Citation Score: 258.40867000000003
- Max Citation Score: 274.47623
- Similarity Product: 220.2516024172139

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test